Page last updated: 2024-10-26

eburnamonine and Huntington Disease

eburnamonine has been researched along with Huntington Disease in 1 studies

Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martinez-Vicente, M1
Talloczy, Z1
Wong, E1
Tang, G1
Koga, H1
Kaushik, S1
de Vries, R1
Arias, E1
Harris, S1
Sulzer, D1
Cuervo, AM1

Other Studies

1 other study available for eburnamonine and Huntington Disease

ArticleYear
Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease.
    Nature neuroscience, 2010, Volume: 13, Issue:5

    Topics: Animals; Apoptosis; Autophagy; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Hepatocyt

2010